Global Biosimilar Drug Market Growth 2019-2024

Publisher Name :
Date: 12-Feb-2019
No. of pages: 131

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we're using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

According to this study, over the next five years the Biosimilar Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Biosimilar Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

- Injection

- Tablets

- Other Types

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

- Ankylosing Spondylitis

- Tumor

- Rheumatoid Arthrtis

- Cardiovascular

- Other Application

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Amgen

- Eli Lilly

- Novartis

- CP Guojian Pharma

- Biotech Pharma

- ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Biosimilar Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of Biosimilar Drug market by identifying its various subsegments.

- Focuses on the key global Biosimilar Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Biosimilar Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Biosimilar Drug submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Biosimilar Drug Market Growth 2019-2024

Table of Contents

2019-2024 Global Biosimilar Drug Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Consumption 2014-2024
2.1.2 Biosimilar Drug Consumption CAGR by Region
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Consumption by Type
2.3.1 Global Biosimilar Drug Consumption Market Share by Type (2014-2019)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biosimilar Drug Sale Price by Type (2014-2019)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Consumption by Application
2.5.1 Global Biosimilar Drug Consumption Market Share by Application (2014-2019)
2.5.2 Global Biosimilar Drug Value and Market Share by Application (2014-2019)
2.5.3 Global Biosimilar Drug Sale Price by Application (2014-2019)

3 Global Biosimilar Drug by Players
3.1 Global Biosimilar Drug Sales Market Share by Players
3.1.1 Global Biosimilar Drug Sales by Players (2017-2019)
3.1.2 Global Biosimilar Drug Sales Market Share by Players (2017-2019)
3.2 Global Biosimilar Drug Revenue Market Share by Players
3.2.1 Global Biosimilar Drug Revenue by Players (2017-2019)
3.2.2 Global Biosimilar Drug Revenue Market Share by Players (2017-2019)
3.3 Global Biosimilar Drug Sale Price by Players
3.4 Global Biosimilar Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Drug by Regions
4.1 Biosimilar Drug by Regions
4.1.1 Global Biosimilar Drug Consumption by Regions
4.1.2 Global Biosimilar Drug Value by Regions
4.2 Americas Biosimilar Drug Consumption Growth
4.3 APAC Biosimilar Drug Consumption Growth
4.4 Europe Biosimilar Drug Consumption Growth
4.5 Middle East & Africa Biosimilar Drug Consumption Growth

5 Americas
5.1 Americas Biosimilar Drug Consumption by Countries
5.1.1 Americas Biosimilar Drug Consumption by Countries (2014-2019)
5.1.2 Americas Biosimilar Drug Value by Countries (2014-2019)
5.2 Americas Biosimilar Drug Consumption by Type
5.3 Americas Biosimilar Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biosimilar Drug Consumption by Countries
6.1.1 APAC Biosimilar Drug Consumption by Countries (2014-2019)
6.1.2 APAC Biosimilar Drug Value by Countries (2014-2019)
6.2 APAC Biosimilar Drug Consumption by Type
6.3 APAC Biosimilar Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Biosimilar Drug by Countries
7.1.1 Europe Biosimilar Drug Consumption by Countries (2014-2019)
7.1.2 Europe Biosimilar Drug Value by Countries (2014-2019)
7.2 Europe Biosimilar Drug Consumption by Type
7.3 Europe Biosimilar Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Drug by Countries
8.1.1 Middle East & Africa Biosimilar Drug Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Biosimilar Drug Value by Countries (2014-2019)
8.2 Middle East & Africa Biosimilar Drug Consumption by Type
8.3 Middle East & Africa Biosimilar Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Drug Distributors
10.3 Biosimilar Drug Customer

11 Global Biosimilar Drug Market Forecast
11.1 Global Biosimilar Drug Consumption Forecast (2019-2024)
11.2 Global Biosimilar Drug Forecast by Regions
11.2.1 Global Biosimilar Drug Forecast by Regions (2019-2024)
11.2.2 Global Biosimilar Drug Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Drug Forecast by Type
11.8 Global Biosimilar Drug Forecast by Application

12 Key Players Analysis
12.1 Amgen
12.1.1 Company Details
12.1.2 Biosimilar Drug Product Offered
12.1.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Amgen News
12.2 Eli Lilly
12.2.1 Company Details
12.2.2 Biosimilar Drug Product Offered
12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Eli Lilly News
12.3 Novartis
12.3.1 Company Details
12.3.2 Biosimilar Drug Product Offered
12.3.3 Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 CP Guojian Pharma
12.4.1 Company Details
12.4.2 Biosimilar Drug Product Offered
12.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 CP Guojian Pharma News
12.5 Biotech Pharma
12.5.1 Company Details
12.5.2 Biosimilar Drug Product Offered
12.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Biotech Pharma News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Figure Biosimilar Drug Report Years Considered
Figure Market Research Methodology
Figure Global Biosimilar Drug Consumption Growth Rate 2014-2024 (K DDD)
Figure Global Biosimilar Drug Value Growth Rate 2014-2024 ($ Millions)
Table Biosimilar Drug Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Injection
Table Major Players of Injection
Figure Product Picture of Tablets
Table Major Players of Tablets
Figure Product Picture of Other Types
Table Major Players of Other Types
Table Global Consumption Sales by Type (2014-2019)
Table Global Biosimilar Drug Consumption Market Share by Type (2014-2019)
Figure Global Biosimilar Drug Consumption Market Share by Type (2014-2019)
Table Global Biosimilar Drug Revenue by Type (2014-2019) ($ million)
Table Global Biosimilar Drug Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Biosimilar Drug Value Market Share by Type (2014-2019)
Table Global Biosimilar Drug Sale Price by Type (2014-2019)
Figure Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure Global Biosimilar Drug Market: Ankylosing Spondylitis (2014-2019) (K DDD)
Figure Global Biosimilar Drug Market: Ankylosing Spondylitis (2014-2019) ($ Millions)
Figure Global Ankylosing Spondylitis YoY Growth ($ Millions)
Figure Biosimilar Drug Consumed in Tumor
Figure Global Biosimilar Drug Market: Tumor (2014-2019) (K DDD)
Figure Global Biosimilar Drug Market: Tumor (2014-2019) ($ Millions)
Figure Global Tumor YoY Growth ($ Millions)
Figure Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure Global Biosimilar Drug Market: Rheumatoid Arthrtis (2014-2019) (K DDD)
Figure Global Biosimilar Drug Market: Rheumatoid Arthrtis (2014-2019) ($ Millions)
Figure Global Rheumatoid Arthrtis YoY Growth ($ Millions)
Figure Biosimilar Drug Consumed in Cardiovascular
Figure Global Biosimilar Drug Market: Cardiovascular (2014-2019) (K DDD)
Figure Global Biosimilar Drug Market: Cardiovascular (2014-2019) ($ Millions)
Figure Global Cardiovascular YoY Growth ($ Millions)
Figure Biosimilar Drug Consumed in Other Application
Figure Global Biosimilar Drug Market: Other Application (2014-2019) (K DDD)
Figure Global Biosimilar Drug Market: Other Application (2014-2019) ($ Millions)
Figure Global Other Application YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Biosimilar Drug Consumption Market Share by Application (2014-2019)
Figure Global Biosimilar Drug Consumption Market Share by Application (2014-2019)
Table Global Biosimilar Drug Value by Application (2014-2019)
Table Global Biosimilar Drug Value Market Share by Application (2014-2019)
Figure Global Biosimilar Drug Value Market Share by Application (2014-2019)
Table Global Biosimilar Drug Sale Price by Application (2014-2019)
Table Global Biosimilar Drug Sales by Players (2017-2019) (K DDD)
Table Global Biosimilar Drug Sales Market Share by Players (2017-2019)
Figure Global Biosimilar Drug Sales Market Share by Players in 2017
Figure Global Biosimilar Drug Sales Market Share by Players in 2018
Table Global Biosimilar Drug Revenue by Players (2017-2019) ($ Millions)
Table Global Biosimilar Drug Revenue Market Share by Players (2017-2019)
Figure Global Biosimilar Drug Revenue Market Share by Players in 2017
Figure Global Biosimilar Drug Revenue Market Share by Players in 2018
Table Global Biosimilar Drug Sale Price by Players (2017-2019)
Figure Global Biosimilar Drug Sale Price by Players in 2018
Table Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Biosimilar Drug Products Offered
Table Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Biosimilar Drug Consumption by Regions 2014-2019 (K DDD)
Table Global Biosimilar Drug Consumption Market Share by Regions 2014-2019
Figure Global Biosimilar Drug Consumption Market Share by Regions 2014-2019
Table Global Biosimilar Drug Value by Regions 2014-2019 ($ Millions)
Table Global Biosimilar Drug Value Market Share by Regions 2014-2019
Figure Global Biosimilar Drug Value Market Share by Regions 2014-2019
Figure Americas Biosimilar Drug Consumption 2014-2019 (K DDD)
Figure Americas Biosimilar Drug Value 2014-2019 ($ Millions)
Figure APAC Biosimilar Drug Consumption 2014-2019 (K DDD)
Figure APAC Biosimilar Drug Value 2014-2019 ($ Millions)
Figure Europe Biosimilar Drug Consumption 2014-2019 (K DDD)
Figure Europe Biosimilar Drug Value 2014-2019 ($ Millions)
Figure Middle East & Africa Biosimilar Drug Consumption 2014-2019 (K DDD)
Figure Middle East & Africa Biosimilar Drug Value 2014-2019 ($ Millions)
Table Americas Biosimilar Drug Consumption by Countries (2014-2019) (K DDD)
Table Americas Biosimilar Drug Consumption Market Share by Countries (2014-2019)
Figure Americas Biosimilar Drug Consumption Market Share by Countries in 2018
Table Americas Biosimilar Drug Value by Countries (2014-2019) ($ Millions)
Table Americas Biosimilar Drug Value Market Share by Countries (2014-2019)
Figure Americas Biosimilar Drug Value Market Share by Countries in 2018
Table Americas Biosimilar Drug Consumption by Type (2014-2019) (K DDD)
Table Americas Biosimilar Drug Consumption Market Share by Type (2014-2019)
Figure Americas Biosimilar Drug Consumption Market Share by Type in 2018
Table Americas Biosimilar Drug Consumption by Application (2014-2019) (K DDD)
Table Americas Biosimilar Drug Consumption Market Share by Application (2014-2019)
Figure Americas Biosimilar Drug Consumption Market Share by Application in 2018
Figure United States Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure United States Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Canada Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Canada Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Mexico Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Mexico Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Table APAC Biosimilar Drug Consumption by Countries (2014-2019) (K DDD)
Table APAC Biosimilar Drug Consumption Market Share by Countries (2014-2019)
Figure APAC Biosimilar Drug Consumption Market Share by Countries in 2018
Table APAC Biosimilar Drug Value by Countries (2014-2019) ($ Millions)
Table APAC Biosimilar Drug Value Market Share by Countries (2014-2019)
Figure APAC Biosimilar Drug Value Market Share by Countries in 2018
Table APAC Biosimilar Drug Consumption by Type (2014-2019) (K DDD)
Table APAC Biosimilar Drug Consumption Market Share by Type (2014-2019)
Figure APAC Biosimilar Drug Consumption Market Share by Type in 2018
Table APAC Biosimilar Drug Consumption by Application (2014-2019) (K DDD)
Table APAC Biosimilar Drug Consumption Market Share by Application (2014-2019)
Figure APAC Biosimilar Drug Consumption Market Share by Application in 2018
Figure China Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure China Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Japan Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Japan Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Korea Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Korea Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Southeast Asia Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure India Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure India Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Australia Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Australia Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Table Europe Biosimilar Drug Consumption by Countries (2014-2019) (K DDD)
Table Europe Biosimilar Drug Consumption Market Share by Countries (2014-2019)
Figure Europe Biosimilar Drug Consumption Market Share by Countries in 2018
Table Europe Biosimilar Drug Value by Countries (2014-2019) ($ Millions)
Table Europe Biosimilar Drug Value Market Share by Countries (2014-2019)
Figure Europe Biosimilar Drug Value Market Share by Countries in 2018
Table Europe Biosimilar Drug Consumption by Type (2014-2019) (K DDD)
Table Europe Biosimilar Drug Consumption Market Share by Type (2014-2019)
Figure Europe Biosimilar Drug Consumption Market Share by Type in 2018
Table Europe Biosimilar Drug Consumption by Application (2014-2019) (K DDD)
Table Europe Biosimilar Drug Consumption Market Share by Application (2014-2019)
Figure Europe Biosimilar Drug Consumption Market Share by Application in 2018
Figure Germany Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Germany Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure France Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure France Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure UK Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure UK Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Italy Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Italy Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Russia Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Russia Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Spain Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Spain Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Biosimilar Drug Consumption by Countries (2014-2019) (K DDD)
Table Middle East & Africa Biosimilar Drug Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Biosimilar Drug Consumption Market Share by Countries in 2018
Table Middle East & Africa Biosimilar Drug Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Biosimilar Drug Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Biosimilar Drug Value Market Share by Countries in 2018
Table Middle East & Africa Biosimilar Drug Consumption by Type (2014-2019) (K DDD)
Table Middle East & Africa Biosimilar Drug Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Biosimilar Drug Consumption Market Share by Type in 2018
Table Middle East & Africa Biosimilar Drug Consumption by Application (2014-2019) (K DDD)
Table Middle East & Africa Biosimilar Drug Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Biosimilar Drug Consumption Market Share by Application in 2018
Figure Egypt Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Egypt Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure South Africa Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure South Africa Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Israel Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Israel Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure Turkey Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure Turkey Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Biosimilar Drug Consumption Growth 2014-2019 (K DDD)
Figure GCC Countries Biosimilar Drug Value Growth 2014-2019 ($ Millions)
Table Biosimilar Drug Distributors List
Table Biosimilar Drug Customer List
Figure Global Biosimilar Drug Consumption Growth Rate Forecast (2019-2024) (K DDD)
Figure Global Biosimilar Drug Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Biosimilar Drug Consumption Forecast by Countries (2019-2024) (K DDD)
Table Global Biosimilar Drug Consumption Market Forecast by Regions
Table Global Biosimilar Drug Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Biosimilar Drug Value Market Share Forecast by Regions
Figure Americas Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Americas Biosimilar Drug Value 2019-2024 ($ Millions)
Figure APAC Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure APAC Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Europe Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Europe Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Middle East & Africa Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Middle East & Africa Biosimilar Drug Value 2019-2024 ($ Millions)
Figure United States Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure United States Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Canada Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Canada Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Mexico Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Mexico Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Brazil Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Brazil Biosimilar Drug Value 2019-2024 ($ Millions)
Figure China Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure China Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Japan Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Japan Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Korea Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Korea Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Southeast Asia Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Southeast Asia Biosimilar Drug Value 2019-2024 ($ Millions)
Figure India Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure India Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Australia Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Australia Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Germany Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Germany Biosimilar Drug Value 2019-2024 ($ Millions)
Figure France Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure France Biosimilar Drug Value 2019-2024 ($ Millions)
Figure UK Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure UK Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Italy Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Italy Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Russia Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Russia Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Spain Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Spain Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Egypt Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Egypt Biosimilar Drug Value 2019-2024 ($ Millions)
Figure South Africa Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure South Africa Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Israel Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Israel Biosimilar Drug Value 2019-2024 ($ Millions)
Figure Turkey Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure Turkey Biosimilar Drug Value 2019-2024 ($ Millions)
Figure GCC Countries Biosimilar Drug Consumption 2019-2024 (K DDD)
Figure GCC Countries Biosimilar Drug Value 2019-2024 ($ Millions)
Table Global Biosimilar Drug Consumption Forecast by Type (2019-2024) (K DDD)
Table Global Biosimilar Drug Consumption Market Share Forecast by Type (2019-2024)
Table Global Biosimilar Drug Value Forecast by Type (2019-2024) ($ Millions)
Table Global Biosimilar Drug Value Market Share Forecast by Type (2019-2024)
Table Global Biosimilar Drug Consumption Forecast by Application (2019-2024) (K DDD)
Table Global Biosimilar Drug Consumption Market Share Forecast by Application (2019-2024)
Table Global Biosimilar Drug Value Forecast by Application (2019-2024) ($ Millions)
Table Global Biosimilar Drug Value Market Share Forecast by Application (2019-2024)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Amgen Biosimilar Drug Market Share (2017-2019)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Eli Lilly Biosimilar Drug Market Share (2017-2019)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Novartis Biosimilar Drug Market Share (2017-2019)
Table CP Guojian Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
Figure CP Guojian Pharma Biosimilar Drug Market Share (2017-2019)
Table Biotech Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Biotech Pharma Biosimilar Drug Market Share (2017-2019)
  • Global and China Oncology Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 27-Sep-2019        Price: US 2000 Onwards        Pages: 68
    Summary Market Segment as follows: By Type - G-CSF - Hematopoietic Agents - Monoclonal Antibodies By Application - Retail Pharmacies - Hospital Pharmacies - Online Pharmacies By Company - Celltrion Inc. - Pfizer Inc. - Biocon - BIOCAD - Apotex Inc. - Dr. Reddy's - Sandoz International GmbH - Intas Pharmaceuticals Ltd. - STADA Arzneimittel AG......
  • Global Oncology Biosimilars Market Professional Survey Report 2019
    Published: 23-Sep-2019        Price: US 3500 Onwards        Pages: 108
    Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry......
  • Global Adalimumab Biosimilar Market Study 2016-2026, by Segment (Tablet, Oral Solution) , by Market (Hospital Pharmacy, Retail Pharmacy, … …) , by Company (AET BioTech, Amgen, … …)
    Published: 21-Sep-2019        Price: US 1800 Onwards        Pages: 56
    Summary The global Adalimumab Biosimilar market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Tablet - Oral Solution Demand Coverage (Market Size & Forecast, Consumer Distribution): - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy Company Coverage (Sales data, Main Products & Serv......
  • Global Biosimilar Monoclonal Antibodies Industry Market Research Report
    Published: 12-Sep-2019        Price: US 2960 Onwards        Pages: 111
    The Biosimilar Monoclonal Antibodies market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Biosimilar Monoclonal Antibodies industrial chain, this report mainly elaborates the definition, types, applications and major players of Biosimilar Monoclonal Antibodies market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disad......
  • Global Biosimilar Drug Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 30-Aug-2019        Price: US 2900 Onwards        Pages: 196
    The Biosimilar Drug market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Biosimilar Drug. Global Biosimilar Drug industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue,......
  • Global and China Adalimumab Biosimilar Market Research by Company, Type & Application 2013-2025
    Published: 28-Aug-2019        Price: US 2000 Onwards        Pages: 73
    Summary Market Segment as follows: By Type - Tablet - Oral Solution By Application - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy By Company - AET BioTech - Amgen - Boehringer Ingelheim - Coherus Biosciences - Fujifilm Kyowa Kirin Biologics - LG Life Sciences/Mochida Pharmaceutical - Momenta Pharmaceuticals - Oncobiologics - Pfizer ......
  • Global and China Biologics and Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Aug-2019        Price: US 2000 Onwards        Pages: 83
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global and China Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Aug-2019        Price: US 2000 Onwards        Pages: 80
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Market Segment as follows: By Type - Injection - Tablets - Others By Application - Ankylosing Spondylitis - Tumor - Rheumatoid Arthrtis - Cardiovascular By Company......
  • Global Adalimumab Biosimilar Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 16-Aug-2019        Price: US 3000 Onwards        Pages: 95
    Summary The report forecast global Adalimumab Biosimilar market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Adalimumab Biosimilar industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Adalimumab Biosimilar by geography. The report splits the market size, by volume......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs